skip navigation links
National Cancer Institute
Enterprise Vocabulary Services
Box
NCIm Version: 201808 (Browser Version 2.9, using LexEVS 6.5.1)
SearchBox Top
SearchBox Bottom
Hyperuricemia (CUI C0740394) Suggest changes to this concept
Add to Cart

Terms & Properties

Concept Unique Identifier (CUI): C0740394

NCI Thesaurus Code: C3961  (see NCI Thesaurus info)

Semantic Type: Disease or Syndrome

NCIt Definition: Elevated blood concentrations of uric acid.

HPO Definition: An abnormally high level of uric acid in the blood. [HPO:probinson]

NCI-GLOSS Definition: A buildup of uric acid (a byproduct of metabolism) in the blood. Hyperuricemia is a side effect of some anticancer drugs.

CTCAE Definition: A disorder characterized by laboratory test results that indicate an elevation in the concentration of uric acid.

NICHD Definition: Abnormally high level of uric acid in the blood.

CSP Definition: excessive uric acid or urate in blood as defined by its solubility in plasma at 37 degrees Celsius; greater than 0.42mmol per liter (7.0mg/dl) in men or 0.36mmol per liter (6.0mg/dl) in women; this condition is caused by overproduction of uric acid or impaired renal clearance; hyperuricemia can be acquired, drug-induced or genetically determined; it is associated with hypertension and gout.

MSH Definition: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.

Synonyms & Abbreviations: (see Synonym Details)
High blood uric acid level
HYPERURICAEMIA
Hyperuricaemic
Hyperuricemia (disorder)
Hyperuricemia [Disease/Finding]
HYPERURICEMIA
URIC ACID ELEVATED
URIC ACID RETENTION
Uricacidaemia
uricacidemia

External Source Codes: 
NCI Thesaurus Code C3961 (see NCI Thesaurus info)

Other Properties: Property Definitions
Name Value Source
ACTIVE 1 SNOMEDCT_US
AQL BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI MSH
CASE_SIGNIFICANCE_ID 900000000000448009 SNOMEDCT_US
Contributing_Source CTRP NCI
Contributing_Source MedDRA NCI
Contributing_Source NICHD NCI
CTV3ID XUCSi SNOMEDCT_US
DC 1 MSH
DEFINITION_STATUS_ID 900000000000074008 SNOMEDCT_US
DID 1849-8097 CSP
DX 20030101 MSH
EFFECTIVE_TIME 20020131 SNOMEDCT_US
HN 2003 MSH
MDA 20020703 MSH
MESH_DEFINITION Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT. NDFRT
MESH_DUI D033461 NDFRT
MESH_NAME Hyperuricemia NDFRT
MESH_UI M0402804 NDFRT
MMR 20060705 MSH
MN C23.550.449 MSH
NCI_THESAURUS_CODE C3961 PDQ
NDFRT_KIND DISEASE_KIND NDFRT
NICHD_Hierarchy_Term Hyperuricemia NCI
NUI N0000010234 NDFRT
ORIG_STY Secondary related condition PDQ
PID 5634 PDQ
PM 2003 MSH
PRIMARY_PATH 10020903$10070968$10037546$10027433$Hyperuricaemia$Disorders of purine metabolism$Purine and pyrimidine metabolism disorders$Metabolism and nutrition disorders MDR
PRIMARY_SOC 10027433 MDR
PT_IN_VERSION 10.0 MDR
PT_IN_VERSION 10.1 MDR
PT_IN_VERSION 11.0 MDR
PT_IN_VERSION 11.1 MDR
PT_IN_VERSION 12.0 MDR
PT_IN_VERSION 12.1 MDR
PT_IN_VERSION 13.0 MDR
PT_IN_VERSION 13.1 MDR
PT_IN_VERSION 14.0 MDR
PT_IN_VERSION 14.1 MDR
PT_IN_VERSION 15.0 MDR
PT_IN_VERSION 15.1 MDR
PT_IN_VERSION 16.0 MDR
PT_IN_VERSION 16.1 MDR
PT_IN_VERSION 17.0 MDR
PT_IN_VERSION 17.1 MDR
PT_IN_VERSION 18.0 MDR
PT_IN_VERSION 18.1 MDR
PT_IN_VERSION 19.0 MDR
PT_IN_VERSION 19.1 MDR
PT_IN_VERSION 20.0 MDR
PT_IN_VERSION 20.1 MDR
PT_IN_VERSION 8.0 MDR
PT_IN_VERSION 8.1 MDR
PT_IN_VERSION 9.0 MDR
PT_IN_VERSION 9.1 MDR
REF http://orcid.org/0000-0001-5208-3432 HPO
RXAUI 3174688 RXNORM
RXAUI 3174689 RXNORM
RXCUI 1022056 RXNORM
SMQ_TERM_ADDVERSION 16.1 MDR
SMQ_TERM_CAT B MDR
SMQ_TERM_LEVEL 4 MDR
SMQ_TERM_LEVEL 5 MDR
SMQ_TERM_LMVERSION 16.1 MDR
SMQ_TERM_SCOPE 1 MDR
SMQ_TERM_STATUS A MDR
SMQ_TERM_WEIGHT 0 MDR
SNOMED_CID 35885006 NDFRT
SUBSET_MEMBER 447562003~CORRELATIONID~447561005 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPADVICE~ALWAYS E79.0 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPCATEGORYID~447637006 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPGROUP~1 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPPRIORITY~1 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPRULE~TRUE SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPTARGET~E79.0 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~CORRELATIONID~447561005 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPADVICE~ALWAYS E79.0 | DESCENDANTS NOT EXHAUSTIVELY MAPPED SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPCATEGORYID~447637006 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPGROUP~1 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPPRIORITY~1 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPRULE~TRUE SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPTARGET~E79.0 SNOMEDCT_US
SUBSET_MEMBER 900000000000497000~MAPTARGET~XUCSi SNOMEDCT_US
SUBSET_MEMBER 900000000000508004~ACCEPTABILITYID~900000000000548007 SNOMEDCT_US
SUBSET_MEMBER 900000000000508004~ACCEPTABILITYID~900000000000549004 SNOMEDCT_US
SUBSET_MEMBER 900000000000509007~ACCEPTABILITYID~900000000000548007 SNOMEDCT_US
SUBSET_MEMBER 900000000000509007~ACCEPTABILITYID~900000000000549004 SNOMEDCT_US
TERMUI T467493 MSH
TH NLM (2003) MSH
TYPE_ID 900000000000003001 SNOMEDCT_US
TYPE_ID 900000000000013009 SNOMEDCT_US

Additional Concept Data:  (none)

URL to Bookmark: https://ncim-stage.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&code=C0740394

Mainbox Bottom